PATENT CLAIM ANALYSIS

Application Number: 15753688
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-09
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to compositions and methods for the treatment and prevention of canine influenza virus (CIV) and CIV-related pathology. The present invention is based in part upon the discovery that one or more mutations in segment 4 of the viral genome produces a single cycle infectious CIV (sciCIV). The sciCIV does not allow for the production of infectious progeny, but is able to induce a CIV-specific immune response.

Claim (Index 11):
The method of  claim 7 , wherein the sciCIV is derived from H3N8 subtype of influenza A virus.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 88.0
- Lexical Diversity: 1.41818
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15753671', '14109358', '15158785', '15846735', '14374061']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7351666459488884
- 35 USC 102 Novelty (BERT): 0.5788201797043281
- Combined Prediction Score: 0.7195319993244323
- Mean Citation Score: 369.26887
- Max Citation Score: 526.33734
- Similarity Product: 369.2329215959108

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test